Riik: Malaisia
keel: inglise
Allikas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
PREDNISOLONE
DYNAPHARM (M) SDN BHD
PREDNISOLONE
100 ml; 60 ml
DYNAPHARM (M) SDN BHD
Consumer Medication Information Leaflet (RiMUP) PREDSOLONE SYRUP Prednisolone (2.5 mg / 5ml) 1 What is in this leaflet 1. What Predsolone Syrup is used for 2. How Predsolone Syrup works 3. Before you use Predsolone Syrup 4. How to use Predsolone Syrup 5. While you are using it 6. Side effects 7. Storage and Disposal of Predsolone Syrup 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of revision What Predsolone Syrup is used for Predsolone Syrup is used for conditions that are responsive to this type of steroid therapy such as asthma, skin reactions and inflammatory bowel disease. How Predsolone Syrup works Prednisolone has anti-inflammatory action, anti-allergic, anti-shock (sudden drop of blood flow) and act to suppress or prevent the immune response. Before you use Predsolone Syrup - When you must not use it Do not use Predsolone Syrup if you have: - Fragile bones - Active ulcer or mental disorder - Infections unless effective with specific concurrent medicines - Undergoing immunisations. Pregnancy and lactation Do not take Predsolone Syrup if you are pregnant, trying to get pregnant or think you may be pregnant. Do not take Predsolone Syrup if you are breast-feeding. Ask your doctor or pharmacist for advice before taking any medicine. Some medicines may increase the effects of Predsolone Syrup and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV such as cobicistat) - Before you start use it Tell your doctor or pharmacist if you have: - Diabetes - Stomach or intestinal ulcer - Heart disease - High blood pressure - High lipid (fats) content in blood - Underactive thyroid gland - Muscle weakness - Kidney function impairment or stones - Pheochromocytoma (a tumour of the adrenal gland) Talk to your doctor before taking Predsolone Syrup, if you have: Systemic sclerosis (an autoimmune disorder). Taking daily doses of 15mg or more may increase the risk of a serious complication called scleroderma renal crisis which may cau Lugege kogu dokumenti
PREDSOLONE SYRUP MAL19910171AZ DESCRIPTION: SYRUP Colour : Red Flavour : Apricot CONTENT: Each 5 ml contains: Prednisolone ......................................................... 2.5 mg Preservatives: Methyl Paraben 0.1% w/v, Propyl Paraben 0.01% w/v & Sodium Benzoate 0.1% w/v PHARMACODYNAMICS: Prednisolone is a synthetic adrenocorticoid hormone. It has anti-inflammatory action, a weaker sodium-retaining effect than cortisone in normal dosage, anti-allergic, antishock and immunosuppressant action. At cellular level, it diffuses across cell membranes and complexes then enter the cell nucleus, bind to DNA and stimulate transcription of mRNA and subsequent protein synthesis of various enzymes thought to be responsible for the glucocorticoid effects and mineralocorticoid effects. PHARMACOKINETICS: Prednisolone is absorbed after oral administration. The biological half-life is about 3 hours. About 50 % is bound to plasma proteins. It is metabolised by reduction to 20-dihydroprednisolone, 20-dihydroprednisone and hydrocortisone and conjugation occur to some extent. About 10 to 30 % of a dose is excreted in the urine as unchanged prednisolone and the remainder as metabolites, 60 to 80 % of which is conjugated; a dose is completely excreted in 3 days. Prednisolone is excreted in milk in insignificant amounts. INDICATION: Corticosteroid indicated conditions include allergic disorders such as bronchial asthma & allergic skin reactions; blood disorders; selected collagen & rheumatic disorders; connective tissue disorders; gastrointestinal disorders such as inflammatory bowel disease, and also disorders responsive to adrenocortical hormone therapy. RECOMMENDED DOSE: Adults : 5 - 60 mg daily in 2 - 4 divided doses depending on the disease being treated. Children : 0.14 - 2 mg/kg body weight in 4 divided doses or 4 - 6 mg/meter square daily in 4 divided doses. ROUTE OF ADMINISTRATION: FOR ORAL USE ONLY CONTRAINDICATIONS: Osteoporosis; active ulcer, psychoses or severe psychoneuroses. Systematic fungal infections. Acute infec Lugege kogu dokumenti